Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03771287 · ClinicalTrials.gov registry record · NA
Hearing Aid Noise Reduction in Pediatric Users (Oticon Study)
A NA study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03771287 is a NA study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 40 participants.
The verdict
NCT03771287, a NA study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of OpenSound Navigator (OSN), a hearing aid speech-enhancement algorithm developed by Oticon, as treatment for pediatric hearing aid users. Using a double-blind experimental design, the investigators aim to compare two treatment groups of pediatric (ages 6-12) patients with symmetrical sensorineural hearing losses ranging from the mild to moderately-severe degree. One group will be fit with bilateral Oticon OPN™ behind-the-ear hearing aids set with an omni-directional microphone setting. The other group will be fit with the same hearing aid model with the OSN algorithm enabled. Participants from the groups will be age and audiogram-matched. The investigators will evaluate hearing aid benefit through word recognition in noise (behavioral testing) and everyday hearing/listening abilities (parental/legal guardian reported) at hearing aid fitting and 6-8 months post fitting.
Interventions
- DEVICE Oticon OpenSound Navigator speech enhancement algorithm
- DEVICE Oticon omni-directional microphone algorithm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2020-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03771287
The ClinicalTrials.gov registry entry for NCT03771287 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oticon OpenSound Navigator speech enhancement algorithm is the first listed.
NCT03771287 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03771287 about?
NCT03771287 is a clinical study titled "Hearing Aid Noise Reduction in Pediatric Users (Oticon Study)". The purpose of this study is to evaluate the efficacy of OpenSound Navigator (OSN), a hearing aid speech-enhancement algorithm developed by Oticon, as treatment for pediatric hearing aid users. Using a double-blind experimental design, the investigators aim to compare two treatment groups of pediatr...
What is the current status of trial NCT03771287?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-12-05. Estimated completion is 2020-08-30.
What interventions are being tested in trial NCT03771287?
The interventions under investigation include: Oticon OpenSound Navigator speech enhancement algorithm (DEVICE), Oticon omni-directional microphone algorithm (DEVICE).
Who is sponsoring clinical trial NCT03771287?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.